| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |